Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Zhang, Jinghui
Walsh, Michael F.
Wu, Gang
Edmonson, Michael N.
Gruber, Tanja A.
Easton, John
Hedges, Dale
Ma, Xiaotu
Zhou, Xin
Yergeau, Donald A.
Wilkinson, Mark R.
Vadodaria, Bhavin
Chen, Xiang
McGee, Rose B.
Hines-Dowell, Stacy
Nuccio, Regina
Quinn, Emily
Shurtleff, Sheila A.
Rusch, Michael
Patel, Aman
Becksfort, Jared B.
Wang, Shuoguo
Weaver, Meaghann S.
Ding, Li
Mardis, Elaine R.
Wilson, Richard K.
Gajjar, Amar
Ellison, David W.
Pappo, Alberto S.
Pui, Ching-Hon
Nichols, Kim E.
and
Downing, James R.
2015.
Germline Mutations in Predisposition Genes in Pediatric Cancer.
New England Journal of Medicine,
Vol. 373,
Issue. 24,
p.
2336.
Pimentel-Gutiérrez, Helia Judith
Bobadilla-Morales, Lucina
Barba-Barba, César Cenobio
Ortega-De-La-Torre, Citlalli
Sánchez-Zubieta, Fernando Antonio
Corona-Rivera, Jorge Román
González-Quezada, Betsy Annel
Armendáriz-Borunda, Juan S.
Silva-Cruz, Rocío
and
Corona-Rivera, Alfredo
2016.
Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-κB.
Oncology Letters,
Vol. 12,
Issue. 5,
p.
4117.
Kim, Jieun
Lyu, Chuhl Joo
Shin, Saeam
Lee, Seung-Tae
and
Choi, Jong Rak
2016.
Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
Annals of Laboratory Medicine,
Vol. 36,
Issue. 5,
p.
475.
Figueiredo, Lisa
Cole, Peter D.
and
Drachtman, Richard A.
2016.
Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
Expert Review of Hematology,
Vol. 9,
Issue. 3,
p.
227.
Azarnezhad, Asaad
and
Mehdipour, Parvin
2017.
Cancer Genetics and Psychotherapy.
p.
79.
Pariury, Holly
Willhoite, John
Michlitsch, Jennifer
and
Agrawal, Anurag
2019.
Potassium supplementation mitigates corticosteroid-induced neuropsychiatric effects in pediatric oncology patients.
Pediatric Hematology and Oncology,
Vol. 36,
Issue. 7,
p.
445.
YAZAL ERDEM, Arzu
and
ÖZBEK, Namık Yaşar
2020.
Lösemili Çocuklarda SARS COV-2 Enfeksiyonu.
Turkish Journal of Pediatric Disease,
p.
41.
Wang, Haijun
Mejia, Maria Carmenza
Gonzalez, Sandra J.
Zoorob, Roger J.
Chai, Weiwen
and
Du, Xianglin L.
2021.
Cancer incidence and survival trends among infants in the United States from 1975 to 2014.
Pediatric Blood & Cancer,
Vol. 68,
Issue. 4,
Galán-Gómez, Víctor
Matamala, Nerea
Ruz-Caracuel, Beatriz
Valle-Simón, Paula
Ochoa-Fernández, Bárbara
Guerra-García, Pilar
Pernas-Sánchez, Alicia
Minguillón, Jordi
González, Berta
Martínez-Romera, Isabel
Román-Pacheco, Sonsoles
Estival-Monteliú, Pablo
Ibáñez-Navarro, Adrián
Pérez-Martínez, Antonio
and
Escudero-López, Adela
2022.
Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine.
Journal of Personalized Medicine,
Vol. 12,
Issue. 6,
p.
881.
Helenius, Marianne
Vaitkeviciene, Goda
Abrahamsson, Jonas
Jonsson, Ólafur Gisli
Lund, Bendik
Harila‐Saari, Arja
Vettenranta, Kim
Mikkel, Sirje
Stanulla, Martin
Lopez‐Lopez, Elixabet
Waanders, Esmé
Madsen, Hans O.
Marquart, Hanne Vibeke
Modvig, Signe
Gupta, Ramneek
Schmiegelow, Kjeld
and
Nielsen, Rikke Linnemann
2022.
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study.
Pediatric Blood & Cancer,
Vol. 69,
Issue. 6,
Mejía-Aranguré, Eréndira
Reyes-López, Alfonso
Juárez-Villegas, Luis Enrique
Hernández-Olivares, Yosef Olaf
Saucedo-Campos, Alberto Daniel
Hernández-Pliego, Gabriela
Martínez-Valverde, Silvia
Barajas-Nava, Leticia A.
and
Garduño-Espinosa, Juan
2022.
Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL).
BMC Health Services Research,
Vol. 22,
Issue. 1,
Temuroğlu, Aytül
Güler, Salih
Aksoy, Gökalp Rüstem
Evim, Melike Sezgin
and
Güneş, Adalet Meral
2023.
Is there a risk of early relapse in patients with acute lymphoblastic leukemia presenting with bone-associated symptoms?.
Journal of Surgery and Medicine,
Vol. 7,
Issue. 1,
p.
40.